Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Geoffrey Gurtner

Plastic and Reconstructive Surgery Palo Alto, CA Medical Doctor

NPI 1891830881 CMS profile 40466

900 Blake Wilbur Dr, Plastic Surgery Clinic, Palo Alto, CA 94304

Open in the dashboard

General payments

$127,158

88 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$56,250 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Geoffrey Gurtner of Palo Alto, CA is reported in the CMS Open Payments database as having received $127,158 across 88 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $56,250 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,444 29
2024 General $14,975 9
2023 General $32,145 5
2022 General $16,012 13
2021 General $10,358 11
2020 General $18,022 6
2019 General $16,202 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Geoffrey Gurtner
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Geoffrey Gurtner were reported at $19,444. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Geoffrey Gurtner Plastic and Reconstructive Surgery median Middle half National median
2019 $16,202 $335 $121–$1,264 $163
2020 $18,022 $162 $57–$417 $114
2021 $10,358 $245 $89–$735 $132
2022 $16,012 $325 $120–$932 $149
2023 $32,145 $343 $129–$999 $160
2024 $14,975 $390 $141–$1,085 $164
2025 $19,444 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Molnlycke Health Care US, LLC $40,628 11 payments
  2. Medline Industries, Inc. $26,192 19 payments
  3. Davol Inc. $23,757 13 payments
  4. Novo Nordisk AS $14,680 6 payments
  5. Misonix Inc $9,464 4 payments
  6. Osiris Therapeutics Inc. $6,082 4 payments
  7. AbbVie, Inc. $3,134 9 payments
  8. Solventum Corporation $800 1 payment
  9. Bimini Technologies LLC $500 1 payment
  10. Integra LifeSciences Corporation $403 4 payments
  11. Other $1,519 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $94,639 28 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,342 3 payments
  3. Honoraria $10,100 5 payments
  4. Travel and Lodging $6,835 10 payments
  5. Food and Beverage $3,843 41 payments
  6. Education $400 1 payment
Products named General payments · program years 2019–2025
  1. Dermatology and Wound Care Dermatology and Wound Care $14,457 6 payments
  2. Avance Solo $6,750 1 payment
  3. GRAFIX $6,082 4 payments
  4. GrafixPL $6,082 4 payments
  5. Dermatology and Wound Care Dermatology/Wound Care $5,323 4 payments
  6. PREVENA $800 1 payment
  7. V.A.C. VERAFLO $800 1 payment
  8. V.A.C. VERAFLO CLEANSE CHOICE $800 1 payment
  9. ABTHERA $800 1 payment
  10. Integra $403 4 payments
  11. Other $5,667 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 17 billing codes

Paid by Medicare

$14,609

Medicare's payments for the services billed

Medicare patients

17

Average age 70

Services billed

56

17 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 75%
COPD 0%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

88 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record